Skip to Main Content

Paper Details

Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Drug Saf
7
2020
Author NameAffiliation
Rebecca N JeromeVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Meghan Morrison JolyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Jana K Shirey-RiceVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University
Gordon R BernardVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Kenneth J HolroydVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Kenneth J HolroydCenter for Technology Transfer and Commercialization, Vanderbilt University
Joshua C DennyVanderbilt University
Jill M PulleyVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
  • 1 - 11

Datasets

Release 1.2